Discovery of novel hydroxyamidine based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors.
Zhou J, Yu LZ, Fan YL, Guo CH, Lv XM, Zhou ZY, Huang HD, Miao DD, Zhang SP, Li XY, Zhao PP, Liu XP, Hu WH, Zhang C.
Zhou J, et al. Among authors: zhang c, zhang sp.
Eur J Med Chem. 2023 Jan 5;245(Pt 1):114860. doi: 10.1016/j.ejmech.2022.114860. Epub 2022 Oct 29.
Eur J Med Chem. 2023.
PMID: 36370550